Mortality in patients with acute myocardial infarction who receive thrombolytic therapy is not related to the number of thrombolytic interventions performed in a hospital

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1240, 2000-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombolytic Therapy in Acute Myocardial Infarction

By Priglinger U.   Huber K.  

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 301-312

Adis International

Access to resources Recommend Favorite

Utilisation of Thrombolytic Therapy in Older Patients with Myocardial Infarction

By Woods K.L.   Ketley D.  

Drugs & Aging, Vol. 13, Iss. 6, 1998-12 ,pp. : 435-441

Adis International

Access to resources Recommend Favorite

Guidelines to Reducing Delays in Administration of Thrombolytic Therapy in Acute Myocardial Infarction

By Williams W.L.  

Drugs, Vol. 55, Iss. 5, 1998-05 ,pp. : 689-698

Adis International

Access to resources Recommend Favorite

Thrombolytic Therapy in the Current ERA: Myocardial Infarction and Beyond

By  

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 414-426

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Unfractionated Heparin and a Low-Molecular-Weight Heparin following Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction

By Wang Xu-Kai   Zhang Ye   Yang Cheng-Ming   Wang Yan   Liu Guang-Yao  

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 341-349

Adis International

Access to resources Recommend Favorite